Diabetes Awareness Month

The Amniox comprehensive family of umbilical cord and amniotic membrane products harnesses the unique power of human birth tissue to help expedite regenerative healing across a wide range of specialties as the adjunct for acute and chronic wound applications by helping to:

• Facilitate wound healing
• Manage discomfort
• Manage adhesions
• Expedite functional recovery while reducing the cost of care ^1-4

Our pioneering scientists have focused on understanding the properties of human birth tissue—ultimately identifying HC-HA/PTX3 as a key orchestrator in healing in the human fetal environment.^5-9

This complex may orchestrate anti-inflammatory, anti-scarring and growth-promoting biological effects that may expedite functional recovery as demonstrated on the ocular space.^5,10

Our CRYOTEK® cryopreservation process has been shown to preserve the structural integrity of the HC-HA/PTX3 complex significantly better than heat dehydration—delivering the benefit of the natural tissue to the wound.^11,12

Industry experts recognize the increasing burden of non-healing wound infections.

14.5% of Medicare beneficiaries in 2014 (8.2 million patients) were diagnosed with at least one type of wound or wound-related infection. Listed by prevalence:

1. Surgical wound infections, the largest category, at 4%
2. Diabetic wound infections 3.4%
3. Non-healing surgical wounds 3%¹³

This cost could range from $31.7 billion to $96.8 billion including wounds as a secondary diagnosis.¹³

• NEOX CORD 1K can help expedite healing in patients with Wagner 3-4 ulcers with an average of 1.5 applications^2,3
• NEOX CORD 1K is suitable for complex wounds with exposure of muscle, tendon and bone where many conventional advanced skin substitutes and skin grafts are contraindicated^2,3
• Our phase II prospective Biologics License Application (BLA) trial reinforces the clinical outcomes¹
• Our product pipeline is focused on patients most at risk for amputation
• Our technology can help reduce the cost of care by helping to expedite functional recovery for the patient^2,4

Clinical Use of NEOX® CORD 1K as an Adjunct Therapy in Promoting Healing of Complex Wounds with Osteomyelitis by Wayne J. Caputo, DPM

Value Appraisal of NEOX® CORD 1K for Complex Diabetic Foot Ulcers by Eric Giza, MD

Clinical Use of NEOX® CORD 1K as an Adjunct Therapy in the Management of a Severe Diabetic Foot with Necrosis of Plantar Muscles and Osteomyelitis by Neil Patel, DPM

Advanced wound therapy treatments are experiencing a rapid adoption rate as an adjunct to the standard of care. In this webinar, Dr. Alan Block provided a contemporary overview of Amniotic Membrane and Umbilical Cord transplantation and shared challenging cases specific to a variety of lower extremity applications where expedited wound healing and functional recovery are a concern.

You can watch Dr. Block’s webinar in its entirety by signing up for the Physician Portal and accessing archived webinars on-demand by clicking the button below.